JP2001354522A - Hair tonic containing ascorbic acid derivative - Google Patents
Hair tonic containing ascorbic acid derivativeInfo
- Publication number
- JP2001354522A JP2001354522A JP2000175580A JP2000175580A JP2001354522A JP 2001354522 A JP2001354522 A JP 2001354522A JP 2000175580 A JP2000175580 A JP 2000175580A JP 2000175580 A JP2000175580 A JP 2000175580A JP 2001354522 A JP2001354522 A JP 2001354522A
- Authority
- JP
- Japan
- Prior art keywords
- ascorbic acid
- hair
- acid
- ester
- acid derivative
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000001256 tonic effect Effects 0.000 title abstract description 4
- 125000003289 ascorbyl group Chemical class [H]O[C@@]([H])(C([H])([H])O*)[C@@]1([H])OC(=O)C(O*)=C1O* 0.000 title 1
- 230000003779 hair growth Effects 0.000 claims abstract description 33
- 150000000996 L-ascorbic acids Chemical class 0.000 claims abstract description 19
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Natural products OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 31
- 229960005070 ascorbic acid Drugs 0.000 claims description 19
- 239000002211 L-ascorbic acid Substances 0.000 claims description 17
- 235000000069 L-ascorbic acid Nutrition 0.000 claims description 17
- -1 L-ascorbic acid fatty acid ester Chemical class 0.000 claims description 15
- 239000000203 mixture Substances 0.000 claims description 15
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 14
- 239000000194 fatty acid Substances 0.000 claims description 14
- 229930195729 fatty acid Natural products 0.000 claims description 14
- 238000002360 preparation method Methods 0.000 claims description 12
- 239000002552 dosage form Substances 0.000 claims description 4
- 150000002148 esters Chemical class 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 4
- 150000004668 long chain fatty acids Chemical class 0.000 claims description 3
- 150000004667 medium chain fatty acids Chemical class 0.000 claims description 3
- IRVNEGRHQKGRGD-WPXUHFOISA-N (2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;hexadecanoic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O.CCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCC(O)=O IRVNEGRHQKGRGD-WPXUHFOISA-N 0.000 claims description 2
- CSTRPYAGFNTOEQ-MGMRMFRLSA-N (2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;octadecanoic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O.CCCCCCCCCCCCCCCCCC(O)=O CSTRPYAGFNTOEQ-MGMRMFRLSA-N 0.000 claims description 2
- KIENGQUGHPTFGC-JLAZNSOCSA-N L-ascorbic acid 6-phosphate Chemical compound OP(=O)(O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O KIENGQUGHPTFGC-JLAZNSOCSA-N 0.000 claims description 2
- 235000010323 ascorbic acid Nutrition 0.000 claims 2
- 239000011668 ascorbic acid Substances 0.000 claims 2
- 239000011786 L-ascorbyl-6-palmitate Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 12
- 206010040880 Skin irritation Diseases 0.000 abstract description 2
- 230000036556 skin irritation Effects 0.000 abstract description 2
- 231100000475 skin irritation Toxicity 0.000 abstract description 2
- 230000001747 exhibiting effect Effects 0.000 abstract 1
- 235000016709 nutrition Nutrition 0.000 abstract 1
- 230000035764 nutrition Effects 0.000 abstract 1
- 201000004384 Alopecia Diseases 0.000 description 9
- 230000003676 hair loss Effects 0.000 description 6
- 150000004665 fatty acids Chemical class 0.000 description 5
- 239000003814 drug Substances 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 208000024963 hair loss Diseases 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 241000208340 Araliaceae Species 0.000 description 3
- QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 description 3
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 3
- 235000003140 Panax quinquefolius Nutrition 0.000 description 3
- 231100000360 alopecia Toxicity 0.000 description 3
- 235000008434 ginseng Nutrition 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- DBSABEYSGXPBTA-RXSVEWSESA-N (2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;phosphoric acid Chemical compound OP(O)(O)=O.OC[C@H](O)[C@H]1OC(=O)C(O)=C1O DBSABEYSGXPBTA-RXSVEWSESA-N 0.000 description 2
- CGFPNELNAZZYQL-RXSVEWSESA-N (2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;sulfuric acid Chemical compound OS(O)(=O)=O.OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CGFPNELNAZZYQL-RXSVEWSESA-N 0.000 description 2
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 2
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 241000219995 Wisteria Species 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 2
- KVYGGMBOZFWZBQ-UHFFFAOYSA-N benzyl nicotinate Chemical compound C=1C=CN=CC=1C(=O)OCC1=CC=CC=C1 KVYGGMBOZFWZBQ-UHFFFAOYSA-N 0.000 description 2
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 159000000007 calcium salts Chemical class 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 208000016252 change in skin color Diseases 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- KEMQGTRYUADPNZ-UHFFFAOYSA-N heptadecanoic acid Chemical compound CCCCCCCCCCCCCCCCC(O)=O KEMQGTRYUADPNZ-UHFFFAOYSA-N 0.000 description 2
- MNWFXJYAOYHMED-UHFFFAOYSA-N heptanoic acid Chemical compound CCCCCCC(O)=O MNWFXJYAOYHMED-UHFFFAOYSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 2
- ISYWECDDZWTKFF-UHFFFAOYSA-N nonadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCCC(O)=O ISYWECDDZWTKFF-UHFFFAOYSA-N 0.000 description 2
- FBUKVWPVBMHYJY-UHFFFAOYSA-N nonanoic acid Chemical compound CCCCCCCCC(O)=O FBUKVWPVBMHYJY-UHFFFAOYSA-N 0.000 description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 2
- SECPZKHBENQXJG-FPLPWBNLSA-N palmitoleic acid Chemical compound CCCCCC\C=C/CCCCCCCC(O)=O SECPZKHBENQXJG-FPLPWBNLSA-N 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 150000004671 saturated fatty acids Chemical class 0.000 description 2
- 159000000000 sodium salts Chemical class 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 239000012085 test solution Substances 0.000 description 2
- ZDPHROOEEOARMN-UHFFFAOYSA-N undecanoic acid Chemical compound CCCCCCCCCCC(O)=O ZDPHROOEEOARMN-UHFFFAOYSA-N 0.000 description 2
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 2
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 1
- BITHHVVYSMSWAG-KTKRTIGZSA-N (11Z)-icos-11-enoic acid Chemical compound CCCCCCCC\C=C/CCCCCCCCCC(O)=O BITHHVVYSMSWAG-KTKRTIGZSA-N 0.000 description 1
- PBTPTBMYJPCXRQ-MGMRMFRLSA-N (2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;hexadecanoic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O.CCCCCCCCCCCCCCCC(O)=O PBTPTBMYJPCXRQ-MGMRMFRLSA-N 0.000 description 1
- MHUOEHQATDLJFZ-WPXUHFOISA-N (2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;octadecanoic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O.CCCCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCCCC(O)=O MHUOEHQATDLJFZ-WPXUHFOISA-N 0.000 description 1
- VSLQHDKDCIFOSH-MGMRMFRLSA-N (2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;tetradecanoic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O.CCCCCCCCCCCCCC(O)=O VSLQHDKDCIFOSH-MGMRMFRLSA-N 0.000 description 1
- MRAMPOPITCOOIN-VIFPVBQESA-N (2r)-n-(3-ethoxypropyl)-2,4-dihydroxy-3,3-dimethylbutanamide Chemical compound CCOCCCNC(=O)[C@H](O)C(C)(C)CO MRAMPOPITCOOIN-VIFPVBQESA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- FRPZMMHWLSIFAZ-UHFFFAOYSA-N 10-undecenoic acid Chemical compound OC(=O)CCCCCCCCC=C FRPZMMHWLSIFAZ-UHFFFAOYSA-N 0.000 description 1
- CIVCELMLGDGMKZ-UHFFFAOYSA-N 2,4-dichloro-6-methylpyridine-3-carboxylic acid Chemical compound CC1=CC(Cl)=C(C(O)=O)C(Cl)=N1 CIVCELMLGDGMKZ-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- LITUBCVUXPBCGA-WMZHIEFXSA-N Ascorbyl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O LITUBCVUXPBCGA-WMZHIEFXSA-N 0.000 description 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 1
- 235000017491 Bambusa tulda Nutrition 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- 238000011735 C3H mouse Methods 0.000 description 1
- 208000019300 CLIPPERS Diseases 0.000 description 1
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 1
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 description 1
- 235000002566 Capsicum Nutrition 0.000 description 1
- 244000020518 Carthamus tinctorius Species 0.000 description 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 1
- 241001107116 Castanospermum australe Species 0.000 description 1
- VQAWRQZAAIQXHM-UHFFFAOYSA-N Cepharanthine Natural products O1C(C=C2)=CC=C2CC(C=23)N(C)CCC3=CC=3OCOC=3C=2OC(=CC=23)C(OC)=CC=2CCN(C)C3CC2=CC=C(O)C1=C2 VQAWRQZAAIQXHM-UHFFFAOYSA-N 0.000 description 1
- 208000032544 Cicatrix Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 240000008067 Cucumis sativus Species 0.000 description 1
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 1
- 235000004866 D-panthenol Nutrition 0.000 description 1
- 239000011703 D-panthenol Substances 0.000 description 1
- 208000003024 Diffuse alopecia Diseases 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- 240000004670 Glycyrrhiza echinata Species 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
- 101000879758 Homo sapiens Sjoegren syndrome nuclear autoantigen 1 Proteins 0.000 description 1
- MIJPAVRNWPDMOR-ZAFYKAAXSA-N L-ascorbic acid 2-phosphate Chemical compound OC[C@H](O)[C@H]1OC(=O)C(OP(O)(O)=O)=C1O MIJPAVRNWPDMOR-ZAFYKAAXSA-N 0.000 description 1
- XDBMXUKHMOFBPJ-ZAFYKAAXSA-N L-ascorbic acid 2-sulfate Chemical compound OC[C@H](O)[C@H]1OC(=O)C(OS(O)(=O)=O)=C1O XDBMXUKHMOFBPJ-ZAFYKAAXSA-N 0.000 description 1
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- ZFMITUMMTDLWHR-UHFFFAOYSA-N Minoxidil Chemical compound NC1=[N+]([O-])C(N)=CC(N2CCCCC2)=N1 ZFMITUMMTDLWHR-UHFFFAOYSA-N 0.000 description 1
- 244000132436 Myrica rubra Species 0.000 description 1
- 235000014631 Myrica rubra Nutrition 0.000 description 1
- 241000234479 Narcissus Species 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 244000170916 Paeonia officinalis Species 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 235000021319 Palmitoleic acid Nutrition 0.000 description 1
- 235000017726 Panax vietnamensis Nutrition 0.000 description 1
- 241001527087 Panax vietnamensis Species 0.000 description 1
- 239000005643 Pelargonic acid Substances 0.000 description 1
- 239000006002 Pepper Substances 0.000 description 1
- 244000082204 Phyllostachys viridis Species 0.000 description 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 1
- 235000016761 Piper aduncum Nutrition 0.000 description 1
- 240000003889 Piper guineense Species 0.000 description 1
- 235000017804 Piper guineense Nutrition 0.000 description 1
- 235000008184 Piper nigrum Nutrition 0.000 description 1
- 241000101040 Pityriasis Species 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 244000299790 Rheum rhabarbarum Species 0.000 description 1
- 235000009411 Rheum rhabarbarum Nutrition 0.000 description 1
- 102100037330 Sjoegren syndrome nuclear autoantigen 1 Human genes 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- POXJXWXPDYFTJM-ZAFYKAAXSA-N [(2r)-2-[(1s)-1,2-dihydroxyethyl]-4-hydroxy-5-oxo-2h-furan-3-yl] dihydrogen phosphate Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1OP(O)(O)=O POXJXWXPDYFTJM-ZAFYKAAXSA-N 0.000 description 1
- TUYRNAGGIJZRNM-LBHUVFDKSA-N [(2s)-2-[(2r)-4-hexadecanoyloxy-3-hydroxy-5-oxo-2h-furan-2-yl]-2-hydroxyethyl] hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(OC(=O)CCCCCCCCCCCCCCC)=C1O TUYRNAGGIJZRNM-LBHUVFDKSA-N 0.000 description 1
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 208000004631 alopecia areata Diseases 0.000 description 1
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000021342 arachidonic acid Nutrition 0.000 description 1
- 229940114079 arachidonic acid Drugs 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 239000011425 bamboo Substances 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- 229950004580 benzyl nicotinate Drugs 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000021279 black bean Nutrition 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- KHAVLLBUVKBTBG-UHFFFAOYSA-N caproleic acid Natural products OC(=O)CCCCCCCC=C KHAVLLBUVKBTBG-UHFFFAOYSA-N 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- RZMKWKZIJJNSLQ-UHFFFAOYSA-M carpronium chloride Chemical compound [Cl-].COC(=O)CCC[N+](C)(C)C RZMKWKZIJJNSLQ-UHFFFAOYSA-M 0.000 description 1
- 229950003631 carpronium chloride Drugs 0.000 description 1
- YVPXVXANRNDGTA-WDYNHAJCSA-N cepharanthine Chemical compound C1C(C=C2)=CC=C2OC(=C2)C(OC)=CC=C2C[C@H](C2=C3)N(C)CCC2=CC(OC)=C3OC2=C(OCO3)C3=CC3=C2[C@H]1N(C)CC3 YVPXVXANRNDGTA-WDYNHAJCSA-N 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 208000021930 chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids Diseases 0.000 description 1
- SECPZKHBENQXJG-UHFFFAOYSA-N cis-palmitoleic acid Natural products CCCCCCC=CCCCCCCCC(O)=O SECPZKHBENQXJG-UHFFFAOYSA-N 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 229960000525 diphenhydramine hydrochloride Drugs 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940108623 eicosenoic acid Drugs 0.000 description 1
- BITHHVVYSMSWAG-UHFFFAOYSA-N eicosenoic acid Natural products CCCCCCCCC=CCCCCCCCCCC(O)=O BITHHVVYSMSWAG-UHFFFAOYSA-N 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000007952 growth promoter Substances 0.000 description 1
- 230000031774 hair cycle Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- YAQXGBBDJYBXKL-UHFFFAOYSA-N iron(2+);1,10-phenanthroline;dicyanide Chemical compound [Fe+2].N#[C-].N#[C-].C1=CN=C2C3=NC=CC=C3C=CC2=C1.C1=CN=C2C3=NC=CC=C3C=CC2=C1 YAQXGBBDJYBXKL-UHFFFAOYSA-N 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 229940010454 licorice Drugs 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- 229960003632 minoxidil Drugs 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 229960002446 octanoic acid Drugs 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-M pentadecanoate Chemical compound CCCCCCCCCCCCCCC([O-])=O WQEPLUUGTLDZJY-UHFFFAOYSA-M 0.000 description 1
- 229950001046 piroctone Drugs 0.000 description 1
- BTSZTGGZJQFALU-UHFFFAOYSA-N piroctone olamine Chemical compound NCCO.CC(C)(C)CC(C)CC1=CC(C)=CC(=O)N1O BTSZTGGZJQFALU-UHFFFAOYSA-N 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 235000008160 pyridoxine Nutrition 0.000 description 1
- 239000011677 pyridoxine Substances 0.000 description 1
- 230000001603 reducing effect Effects 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 230000037387 scars Effects 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- 230000003813 thin hair Effects 0.000 description 1
- 229960002703 undecylenic acid Drugs 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 229930007845 β-thujaplicin Natural products 0.000 description 1
Landscapes
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は、新規な育毛剤に関
するものである。TECHNICAL FIELD The present invention relates to a novel hair restorer.
【0002】[0002]
【従来の技術】一般に、育毛剤、発毛剤、発毛促進剤、
養毛剤等と称される育毛剤は、比較的長期間にわたり連
用されることから、優れた育毛、発毛、発毛促進、養毛
効果を呈するとともに安全性の高いことが要求される。
また、用いる成分が空気や熱などに対し安定なものがさ
らに望ましい。しかしながら、従来知られている成分に
はそれらの効果を兼ね備えたような満足できるものはな
い。2. Description of the Related Art In general, hair restorers, hair growth agents, hair growth promoters,
Since a hair restorer called a hair restorer or the like is used continuously for a relatively long period of time, it is required to have excellent hair growth, hair growth, promotion of hair growth, hair growth effect, and high safety.
Further, it is more desirable that the components used are stable against air, heat, and the like. However, none of the conventionally known components has such a satisfactory effect.
【0003】L−アスコルビン酸誘導体の一部のもの
は、すでに医薬品、食品、化粧品などに安定化剤、抗酸
化剤などの目的で配合されているが、L−アスコルビン
酸誘導体が毛の生長に関与しているという報告はない。Some of the L-ascorbic acid derivatives have already been incorporated into pharmaceuticals, foods, cosmetics, etc. for the purpose of stabilizing agents, antioxidants, etc., but the L-ascorbic acid derivatives have an effect on hair growth. There are no reports of involvement.
【0004】[0004]
【発明が解決しようとしている課題】本発明の目的は、
新規な育毛剤を提供するものである。SUMMARY OF THE INVENTION The object of the present invention is to
A new hair restorer is provided.
【0005】[0005]
【発明を解決するための手段】本発明者らは、上述の問
題を解決でき得る成分としてL−アスコルビン酸誘導体
が有用であることを新たに見出し、本発明を完成した。The present inventors have newly found that an L-ascorbic acid derivative is useful as a component capable of solving the above-mentioned problems, and completed the present invention.
【0006】すなわち、本発明は、L−アスコルビン酸
誘導体を含有する育毛剤、L−アスコルビン酸誘導体を
育毛成分として含有する毛髪用組成物に関する。[0006] That is, the present invention relates to a hair restorer containing an L-ascorbic acid derivative and a hair composition containing the L-ascorbic acid derivative as a hair restorer.
【0007】以下に、本発明について説明する。本発明
における育毛剤とは育毛作用、発毛作用、発毛促進作
用、養毛作用のいずれか、またはそれらの2以上の作用
を有するものを意味しており、いかなる意味においても
限定して解釈してはならない。Hereinafter, the present invention will be described. The hair restorer in the present invention means any of a hair restorer, a hair growth, a hair growth-promoting, and a hair-growth, or a combination of two or more of these. should not be done.
【0008】L−アスコルビン酸は強い還元性を有する
水溶性抗酸化ビタミン(一般にビタミンCともいう)とし
て広く医薬品、食品、化粧品等に用いられているが、水
溶性ビタミンの中では最も安定性が低く、大気中の酸素
により容易に酸化される、また熱に弱く、銅のような金
属が微量に存在していると特に安定性が低いといった問
題があった。さらには、このものは水溶性であるため親
油性のものへの配合が困難である等の問題もあった。こ
れらの問題は近年、L−アスコルビン酸のナトリウム塩
やカルシウム塩等のアルカリ(土類)金属塩や、L−ア
スコルビン酸と脂肪酸、リン酸、硫酸とのエステルとす
ることにより改善される方向にある。本発明はそれらL
−アスコルビン酸誘導体を含有する育毛剤に関するもの
である。[0008] L-ascorbic acid is widely used as a water-soluble antioxidant vitamin (generally also referred to as vitamin C) having strong reducing properties in medicines, foods, cosmetics, etc., but has the highest stability among water-soluble vitamins. It is low, easily oxidized by oxygen in the atmosphere, is weak to heat, and has particularly low stability when a trace amount of metal such as copper is present. Furthermore, since this is water-soluble, it is difficult to mix it with a lipophilic one. In recent years, these problems have been improved by using alkali (earth) metal salts such as sodium salts and calcium salts of L-ascorbic acid, and esters of L-ascorbic acid with fatty acids, phosphoric acid, and sulfuric acid. is there. The present invention relates to those L
-It relates to a hair restorer containing an ascorbic acid derivative.
【0009】以下に、本発明におけるL−アスコルビン
酸誘導体について詳述する。本発明におけるL−アスコ
ルビン酸誘導体としては、具体的には、L−アスコルビ
ン酸脂肪酸エステル、L−アスコルビン酸リン酸エステ
ル、L−アスコルビン酸硫酸エステルおよびこれらの塩
を挙げることができる。Hereinafter, the L-ascorbic acid derivative according to the present invention will be described in detail. Specific examples of the L-ascorbic acid derivative in the present invention include L-ascorbic acid fatty acid ester, L-ascorbic acid phosphate, L-ascorbic acid sulfate and salts thereof.
【0010】本発明においては、L−アスコルビン酸誘
導体としてL−アスコルビン酸脂肪酸エステルが好まし
く、L−アスコルビン酸脂肪酸エステルとしては、L−ア
スコルビン酸と中鎖または長鎖の脂肪酸とのエステルが
好ましい。中鎖脂肪酸としては、炭素数6〜13の飽和
または不飽和の脂肪酸を挙げることができ、具体的に
は、カプロン酸、エナント酸、カプリル酸、ペラルゴン
酸、カプリン酸、ウンデシル酸、ウンデシレン酸、ラウ
リン酸等を挙げることができる。長鎖脂肪酸としては、
炭素数14〜22の飽和または不飽和の脂肪酸を挙げる
ことができ、具体的には、ミリスチン酸、ペンタデカン
酸、パルミチン酸、パルミトレイン酸、マーガリン酸、
ステアリン酸、オレイン酸、リノール酸、リノレン酸、
ノナデカン酸、アラキン酸、エイコセン酸、アラキドン
酸、ベヘン酸等を挙げることができる。L−アスコルビ
ン酸と脂肪酸とのエステルは、L−アスコルビン酸が有
する水酸基1つ以上と脂肪酸がエステル結合して形成さ
れるものであり、複数個の水酸基が脂肪酸とエステル結
合する場合の脂肪酸は同一のものでも、異なったもので
もよい。In the present invention, L-ascorbic acid fatty acid ester is preferable as the L-ascorbic acid derivative, and L-ascorbic acid fatty acid ester is preferably an ester of L-ascorbic acid and a medium-chain or long-chain fatty acid. Examples of the medium-chain fatty acid include a saturated or unsaturated fatty acid having 6 to 13 carbon atoms, and specifically, caproic acid, enanthic acid, caprylic acid, pelargonic acid, capric acid, undecylic acid, undecylenic acid, Lauric acid and the like can be mentioned. As long-chain fatty acids,
Examples thereof include a saturated or unsaturated fatty acid having 14 to 22 carbon atoms, and specifically, myristic acid, pentadecanoic acid, palmitic acid, palmitoleic acid, margaric acid,
Stearic acid, oleic acid, linoleic acid, linolenic acid,
Nonadecanoic acid, arachiic acid, eicosenoic acid, arachidonic acid, behenic acid and the like can be mentioned. The ester of L-ascorbic acid and a fatty acid is formed by one or more hydroxyl groups of L-ascorbic acid and an ester bond of the fatty acid. When a plurality of hydroxyl groups are ester-bonded to the fatty acid, the fatty acids are the same. Or a different one.
【0011】本発明におけるL−アスコルビン酸脂肪酸
エステルとして、例えば、L−アスコルビン酸ミリステ
ート、L−アスコルビン酸パルミテート、L−アスコルビ
ン酸ステアレート、L−アスコルビン酸ジパルミテー
ト、L−アスコルビン酸ジステアレートなどを挙げるこ
とができる。中でも、L−アスコルビン酸−6−パルミ
テート、L−アスコルビン酸−6−ステアレート、L−ア
スコルビン酸−2,6−ジパルミテートが特に好ましい
ものとして挙げることができる。Examples of the L-ascorbic acid fatty acid ester in the present invention include L-ascorbic acid myristate, L-ascorbic acid palmitate, L-ascorbic acid stearate, L-ascorbic acid dipalmitate, L-ascorbic acid distearate and the like. be able to. Among them, L-ascorbic acid-6-palmitate, L-ascorbic acid-6-stearate and L-ascorbic acid-2,6-dipalmitate can be mentioned as particularly preferred.
【0012】L−アスコルビン酸リン酸エステルとして
は、L−アスコルビン酸−2−リン酸エステル、L−アス
コルビン酸−3−リン酸エステル等を挙げることがで
き、L−アスコルビン酸硫酸エステルとしては、L−アス
コルビン酸−2−硫酸エステル、L−アスコルビン酸−
3−硫酸エステル等を挙げることができる。Examples of the L-ascorbic acid phosphate include L-ascorbic acid-2-phosphate, L-ascorbic acid-3-phosphate and the like. Examples of the L-ascorbic acid sulfate include: L-ascorbic acid-2-sulfate, L-ascorbic acid-
3-sulfate ester and the like can be mentioned.
【0013】L−アスコルビン酸脂肪酸エステル、L−ア
スコルビン酸リン酸エステル、L−アスコルビン酸硫酸
エステルは、塩を形成することもあり、塩としてはナト
リウム塩、カリウム塩等のアルカリ金属塩、カルシウム
塩、マグネシウム塩等のアルカリ土類金属塩等を挙げる
ことができる。L-ascorbic acid fatty acid ester, L-ascorbic acid phosphate ester, and L-ascorbic acid sulfate ester may form a salt, and the salt may be an alkali metal salt such as a sodium salt or a potassium salt, or a calcium salt. And alkaline earth metal salts such as magnesium salts.
【0014】これらのL−アスコルビン酸誘導体は公知
の合成的手法により得ることができる。また市販されて
いるL−アスコルビン酸誘導体も使用可能である。These L-ascorbic acid derivatives can be obtained by a known synthetic technique. A commercially available L-ascorbic acid derivative can also be used.
【0015】本発明の育毛剤および毛髪用組成物は、経
口または非経口的に投与することができるが、非経口的
に、直接毛髪頭皮に投与可能な製剤が好ましく、このよ
うな製剤の剤形として外用剤を挙げることができる。具
体的には、経口投与製剤の剤形としては、錠剤、散剤、
カプセル剤、顆粒剤、内服液剤などを挙げることがで
き、非経口投与製剤の剤形としては、ローション剤、エ
アゾール剤などの外用剤、注射剤などを挙げることがで
きる。また、シャンプー、リンス、コンディショナー、
ヘアトニック、ヘアクリーム、ヘアリキッドなどに配合
してもよい。本発明においては、外用剤が剤形として好
ましい。The hair restorer and the composition for hair of the present invention can be administered orally or parenterally, but preparations which can be administered parenterally and directly to the hair scalp are preferred. An external preparation can be mentioned as a form. Specifically, as the dosage form of the oral administration preparation, tablets, powders,
Capsules, granules, oral liquids and the like can be mentioned, and examples of dosage forms of parenteral administration preparations include external preparations such as lotions and aerosols, and injections. Also, shampoo, rinse, conditioner,
You may mix | blend with a hair tonic, a hair cream, a hair liquid, etc. In the present invention, an external preparation is preferable as a dosage form.
【0016】製剤化は公知の製剤技術により行うことが
でき、製剤中には適当な製剤添加物を加えることができ
る。製剤添加物としては、賦形剤、懸濁化剤、乳化剤、
保存剤、保湿剤、香料等を挙げることができる。なお、
製剤中に加える製剤添加物は、製剤の投与量において、
人体等の生体にとって無害であり、また製剤中の有効成
分による効果を妨げないことが必要である。The preparation can be carried out by a known preparation technique, and an appropriate preparation additive can be added to the preparation. Pharmaceutical additives include excipients, suspending agents, emulsifiers,
Preservatives, humectants, fragrances and the like can be mentioned. In addition,
The formulation additives to be added in the formulation, in the dosage of the formulation,
It is necessary to be harmless to the living body such as the human body, and not to hinder the effect of the active ingredient in the preparation.
【0017】製剤化された本発明の育毛剤、すなわち毛
髪用組成物は、使用者の性別、年齢、症状などに応じ
て、適当量を毛髪が減少している部位および/または毛
髪の発生部位に塗布または噴霧等すればよい。製剤中の
L−アスコルビン酸誘導体の配合量としては適宜、使用
者の性別、年齢、症状、使用目的などを考慮して検討す
ればよいが、0.001〜10重量%の範囲内が好ましく、0.0
1〜5重量%の範囲内とするのがより好ましい。The formulated hair restorer of the present invention, that is, the composition for hair, is used in an appropriate amount depending on the sex, age, symptoms, etc. of the user, in a site where hair is reduced and / or a site where hair is generated. May be applied or sprayed. In the formulation
The amount of the L-ascorbic acid derivative may be appropriately determined in consideration of the sex, age, symptoms, purpose of use, etc. of the user, but is preferably in the range of 0.001 to 10% by weight,
More preferably, it is in the range of 1 to 5% by weight.
【0018】さらに、本発明の育毛剤および毛髪用組成
物には、すでに育毛、発毛、発毛促進、養毛効果を有す
る公知の成分をさらに加えてもよい。これらの成分とし
ては、例えば、呉茱萸、五味子、牡丹皮、木瓜、白蘚
皮、五加皮、半夏、大黄、牛膝、枸杞子、茯苓、干姜、
陳皮、甘草、百部、地骨皮、柴胡、天麻、白芍、荊芥、
桂枝、苦参、鳴血藤、骨砕捕、花椒、黄連、人参、黒
豆、何首烏、朝鮮人参、竹節人参、補骨脂、当帰、鶏血
藤、丹参、紅花、桃仁、防風、茜草根、拳参、山茱萸、
半支蓮、楊梅皮、側柏葉および当薬等の生薬並びにこれ
ら生薬の抽出物(チンキ、エキスなど)、さらには塩化
カルプロニウム、パントテニールエチルエーテル、ミノ
キシジール、セファランチン、ニコチン酸ベンジル、ニ
コチン酸アミド、ビオチン、D−パントテニルアルコー
ル、イソプロピルメチルフィノール、ヒノキチオール、
L−メントール、溶性シスチン、オクトピロックス、塩
化ベンザルコニウム、ピリドキシンおよびその誘導体、
サリチル酸、塩酸ジフェンヒドラミン、グリチルリチン
酸、グリチルレチン酸、ペンタデカン酸グリセリドなど
を挙げることができる。これらの成分は、本発明の育毛
剤および毛髪用組成物に単独で加えてもよく、また2種
以上を組み合わせて加えてもよい。Further, to the hair restorer and the composition for hair of the present invention, a known component having a hair growth, hair growth, hair growth promotion and hair growth effect may be further added. As these components, for example, goshuyu, gomiko, peony skin, cucumber, white moss bark, gokahi, midsummer, rhubarb, beef knee, guikoko, bukuryo, dried ginger,
Chen skin, licorice, hundred parts, bone skin, Saiko, Tenma, Hakushoku, thorn,
Keishi, ginseng, narcissus wisteria, bone crushing, pepper, yellow ream, ginseng, black bean, koshu, ginseng, bamboo ginseng, osseous fat, toki, chicken blood wisteria, dansin, safflower, peach, windbreak, Akane Kusane, Kensan, Sanshuyu,
Herbal medicines such as semi-lily, Yangmei skin, side bamboo leaf and this medicine, and extracts of these crude drugs (tinctures, extracts, etc.), furthermore, carpronium chloride, pantothenyl ethyl ether, minoxidil, cepharanthin, benzyl nicotinate, nicotinamide, Biotin, D-pantothenyl alcohol, isopropylmethylfinol, hinokitiol,
L-menthol, soluble cystine, octopirox, benzalkonium chloride, pyridoxine and its derivatives,
Salicylic acid, diphenhydramine hydrochloride, glycyrrhizic acid, glycyrrhetinic acid, glyceride pentadecanoate and the like can be mentioned. These components may be added alone to the hair restorer and the hair composition of the present invention, or may be added in combination of two or more.
【0019】本発明の育毛剤および毛髪用組成物は、具
体的には育毛、発毛、発毛促進および/または養毛用に
用いるものである。したがって、本発明の育毛剤および
毛髪用組成物の効能・効果としては、育毛、発毛、薄
毛、毛生促進、発毛促進、脱毛(抜け毛)の予防、病後
・産後の脱毛、養毛、円形脱毛症、発毛不全、粃糠性脱
毛症、脂漏性脱毛症、びまん性脱毛症、若禿(壮年性脱
毛症)および老人禿等を挙げることができる。The hair restorer and the composition for hair of the present invention are specifically used for hair growth, hair growth, promotion of hair growth and / or hair growth. Therefore, the effects and effects of the hair restorer and the hair composition of the present invention include hair growth, hair growth, thinning hair, promotion of hair growth, promotion of hair growth, prevention of hair loss (hair loss), hair loss after disease and postpartum, hair growth, Alopecia areata, hair loss deficiency, pityriasis alopecia, seborrheic alopecia, diffuse alopecia, young baldness (mature alopecia), and elderly baldness can be mentioned.
【0020】[0020]
【発明の効果】本発明に係るL−アスコルビン酸誘導体
は、優れた育毛、発毛、発毛促進、養毛効果を示した。
またこのものは皮膚刺激等の有害な副作用を示さなかっ
た。したがって、L−アスコルビン酸誘導体は育毛剤の
成分として有用なものである。The L-ascorbic acid derivative according to the present invention has excellent hair growth, hair growth, promotion of hair growth and hair growth.
It did not show any harmful side effects such as skin irritation. Therefore, the L-ascorbic acid derivative is useful as a component of a hair restorer.
【0021】[0021]
【実施例】以下に実施例を示し、本発明をさらに詳細に
説明するが、本発明はこれらの実施例によりなんら限定
されるものではない。 [実施例1]C3Hマウスを用いた毛生長試験 6週齢のC3H/He系雄性マウスを1週間予備飼育し、その後
実験に用いた。すなわち、ヘアサイクルが休止期にある
7週齢のC3H/He系雄性マウスの背部被毛約4〜5cm2の範
囲を電気バリカンで刈り込んだ後、さらに電気シェーバ
ーにより皮膚が完全に見えるまで刈り込んだ。刈り込ん
だ翌日に、傷および残毛のないマウスを選択し、1群10
匹ずつに群分けを行い、マウスの刈毛部に試験液0.1mL
を週5回均一に塗布し、育毛作用について評価した。育
毛作用の指標として刈毛部の皮膚色の変化を色彩色差計
(ミノルタ社製「色彩色差計CR-300:測定径22mm」によ
りL値を測定し、皮膚色の経時変化量(ΔL)を次式によ
り算出した。EXAMPLES The present invention will be described in more detail with reference to the following Examples, which by no means limit the present invention. [Example 1] Hair growth test using C3H mice Six-week-old C3H / He male mice were preliminarily reared for one week and then used in experiments. That is, a 7-week-old C3H / He male mouse with a resting hair cycle was cut with a hair clipper in a range of about 4 to 5 cm 2 of the back coat, and further cut with an electric shaver until the skin was completely visible. . On the day after cutting, select mice without scars and hair residue, and
Each animal was divided into groups.
Was applied evenly five times a week, and the hair growth effect was evaluated. As an index of the hair-growth effect, the change in skin color of the cut hair part is measured using a colorimeter (Minolta “Color-colorimeter CR-300: Measurement diameter 22 mm”) to measure the L value, and the change in skin color over time (ΔL) is measured. It was calculated by the following equation.
【0022】ΔL=開始時のL値−測定時のL値ΔL = L value at start−L value at measurement
【0023】また、試験液を塗布した刈毛部位の変化
(炎症の有無等)を肉眼で観察した。なお、試験液は、
所定の濃度になるように、L−アスコルビン酸−6−パ
ルミテートを100%エタノールに溶解して調製した。結
果を図1に示す。Further, changes (such as presence or absence of inflammation) of the shaved area to which the test solution was applied were visually observed. The test solution was
It was prepared by dissolving L-ascorbic acid-6-palmitate in 100% ethanol to a predetermined concentration. The results are shown in FIG.
【0024】その結果、L−アスコルビン酸−6−パル
ミテートは濃度依存的にマウスの毛生長を促進した。ま
た、塗布した部位の皮膚に炎症等の有害な変化は観察さ
れなかった。As a result, L-ascorbic acid-6-palmitate promoted mouse hair growth in a concentration-dependent manner. In addition, no harmful changes such as inflammation were observed on the skin at the site of application.
【図1】 実施例1の結果を示すグラフである。FIG. 1 is a graph showing the results of Example 1.
───────────────────────────────────────────────────── フロントページの続き Fターム(参考) 4C083 AC102 AD641 AD642 CC37 DD23 EE10 EE22 4C086 AA01 AA02 BA18 MA01 MA04 NA14 ZA92 ──────────────────────────────────────────────────続 き Continued on the front page F term (reference) 4C083 AC102 AD641 AD642 CC37 DD23 EE10 EE22 4C086 AA01 AA02 BA18 MA01 MA04 NA14 ZA92
Claims (7)
毛剤。1. A hair restorer containing an L-ascorbic acid derivative.
ルビン酸脂肪酸エステル、L−アスコルビン酸リン酸エ
ステルおよびL−アスコルビン酸硫酸エステルからなる
群より選ばれる1種または2種以上のものである請求項
1記載の育毛剤。2. The L-ascorbic acid derivative is one or more selected from the group consisting of L-ascorbic acid fatty acid ester, L-ascorbic acid phosphate ester and L-ascorbic acid sulfate ester. Item 10. The hair restorer according to Item 1.
有する育毛剤。3. A hair restorer containing L-ascorbic acid fatty acid ester.
−アスコルビン酸と中鎖または長鎖脂肪酸とのエステル
である請求項3に記載の育毛剤。4. The method according to claim 1, wherein the L-ascorbic acid fatty acid ester is L-ascorbic acid.
The hair restorer according to claim 3, which is an ester of ascorbic acid with a medium-chain or long-chain fatty acid.
−アスコルビン酸パルミテート、L−アスコルビン酸ス
テアレート、L−アスコルビン酸ジパルミテートおよびL
−アスコルビン酸ジステアレートからなる群より選ばれ
る1種または2種以上のものである請求項3または4に
記載の育毛剤。5. The method according to claim 5, wherein the L-ascorbic acid fatty acid ester is L-ascorbic acid.
-Ascorbic acid palmitate, L-ascorbic acid stearate, L-ascorbic acid dipalmitate and L
The hair restorer according to claim 3 or 4, which is one or more kinds selected from the group consisting of ascorbic acid distearate.
して含有する毛髪用組成物。6. A hair composition containing an L-ascorbic acid derivative as a hair growth component.
用組成物。7. The hair composition according to claim 6, wherein the dosage form is an external preparation.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000175580A JP2001354522A (en) | 2000-06-07 | 2000-06-07 | Hair tonic containing ascorbic acid derivative |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000175580A JP2001354522A (en) | 2000-06-07 | 2000-06-07 | Hair tonic containing ascorbic acid derivative |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2001354522A true JP2001354522A (en) | 2001-12-25 |
Family
ID=18677438
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2000175580A Pending JP2001354522A (en) | 2000-06-07 | 2000-06-07 | Hair tonic containing ascorbic acid derivative |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2001354522A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011030816A1 (en) | 2009-09-14 | 2011-03-17 | 国立大学法人北海道大学 | Anti-plant-virus agent |
JP2013018720A (en) * | 2011-07-08 | 2013-01-31 | Kao Corp | Hair treatment composition |
WO2014050894A1 (en) | 2012-09-27 | 2014-04-03 | 日本曹達株式会社 | Ascorbic acid-related compound and anti-plant-virus agent |
WO2018003625A1 (en) * | 2016-06-29 | 2018-01-04 | 日光ケミカルズ株式会社 | Damaged hair-improving agent and damaged hair-improving cosmetic containing same |
-
2000
- 2000-06-07 JP JP2000175580A patent/JP2001354522A/en active Pending
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011030816A1 (en) | 2009-09-14 | 2011-03-17 | 国立大学法人北海道大学 | Anti-plant-virus agent |
US8853172B2 (en) | 2009-09-14 | 2014-10-07 | National University Corporation Hokkaido University | Anti-plant-virus agent |
JP2013018720A (en) * | 2011-07-08 | 2013-01-31 | Kao Corp | Hair treatment composition |
WO2014050894A1 (en) | 2012-09-27 | 2014-04-03 | 日本曹達株式会社 | Ascorbic acid-related compound and anti-plant-virus agent |
WO2018003625A1 (en) * | 2016-06-29 | 2018-01-04 | 日光ケミカルズ株式会社 | Damaged hair-improving agent and damaged hair-improving cosmetic containing same |
JPWO2018003625A1 (en) * | 2016-06-29 | 2019-04-18 | 日光ケミカルズ株式会社 | Damaged hair improving agent and damaged hair improving cosmetic containing the same |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS6341363B2 (en) | ||
JP2019006696A (en) | Active oxygen scavenger | |
JP4554805B2 (en) | Hair nourishing | |
KR101951283B1 (en) | A pharmaceutical or cosmetic composition for preventing or treating a hair loss or stimulating hair growth | |
JPH0645533B2 (en) | Cosmetics | |
KR100616342B1 (en) | Hair tonic composition | |
JP2001354522A (en) | Hair tonic containing ascorbic acid derivative | |
KR102386651B1 (en) | Composition for preventing or treating hair loss comprising tiplaxtinin | |
JP2001278750A (en) | New hair-growing agent | |
JP2004315442A (en) | Gray hair-preventing/improving agent | |
JPH10279437A (en) | Hair cosmetic | |
CA2879847C (en) | Eprotirome for use in the prevention and/or treatment of hair disorders and compositions thereof | |
JP5695310B2 (en) | External preparation composition containing γ-oryzanol | |
JPH11302131A (en) | Cosmetic for scalp and hair | |
JPH09176030A (en) | Medicine for stimulating secretion of sebum | |
JP6920031B2 (en) | Chronic keratinized eczema improving agent | |
JP6156371B2 (en) | Hair growth composition | |
US20250032385A1 (en) | Functional composition for alopecia comprising centipeda minima-derived extract | |
JP6656890B2 (en) | Filaggrin production promoter | |
JPH0640858A (en) | Hair tonic | |
JP2001199843A (en) | Hair growing agent | |
US20170056307A1 (en) | Eprotirome for use in the prevention and/or treatment of hair disorders and compositions thereof | |
WO2013180229A1 (en) | Composition for hair growth | |
JP2004026812A (en) | Hair restoration | |
JPWO2017061610A1 (en) | Hair growth composition |